Evidence map›Paper›PMID 26305429›Full record

ArticleUpsala journal of medical sciences2015

High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional study.

Elizeus Rutebemberwa, Betty Mpeka, George Pariyo, Stefan Peterson, Edison Mworozi, Freddie Bwanga, Karin Källander

Abstract read
In one paragraph

Article in Upsala journal of medical sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Journal of public health in Africa · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The microbiome of the nasopharynx.Journal of medical microbiology · 2021
    Review
  11. Antibiotic Susceptibility ofAntibiotics (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda.Antimicrobial resistance and infection control · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizeus Rutebemberwaa Makerere University School of Public Health , Kampala , Uganda .
Betty Mpekab Abt Associates , Kampala , Uganda .
George Pariyoc Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States .
Stefan Petersona Makerere University School of Public Health , Kampala , Uganda .
Edison Mworozif Department of Paediatrics and Child Health , Makerere University Medical School , Kampala , Uganda .
Freddie Bwangag Department of Microbiology , Makerere University Faculty of Medicine , Kampala , Uganda , and.
Karin Källandera Makerere University School of Public Health , Kampala , Uganda .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Uganda, the main causes of death in children under 5 years of age are malaria and pneumonia--often due to delayed diagnosis and treatment. In preparation for a community case management intervention for pneumonia and malaria, the bacterial composition of the nasopharyngeal flora and its in vitro resistance were determined in children aged five or under to establish baseline resistance to commonly used antibiotics.

methodsIn a population-based survey in April 2008, nasopharyngeal specimens were collected from 152 randomly selected healthy children under 5 years of age in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS). Medical history and prior treatment were recorded. Demographic characteristics and risk factors for carriage of resistant strains were obtained from the HDSS census. Bacteria were isolated and analysed for antibiotic susceptibility using disk diffusion and E test.

resultsStreptococcus pneumoniae (S. pneumoniae) carriage was 58.6%, and, while most (80.9%) isolates had intermediate resistance to penicillin, none was highly resistant. Whereas no isolate was resistant to erythromycin, 98.9% were resistant to trimethoprim-sulphamethoxazole (co-trimoxazole).

conclusionsIn vitro resistance in S. pneumoniae to co-trimoxazole treatment was high, and the majority of isolates had intermediate resistance to penicillin. To inform treatment policies on the clinical efficacy of current treatment protocols for pneumonia in health facilities and at the community level, routine surveillance of resistance in pneumonia pathogens is needed as well as research on treatment efficacy in cases with resistant strains. Improved clinical algorithms and diagnostics for pneumonia should be developed.

Indexed as

Drug Resistance, MicrobialAnti-Bacterial AgentsCarrier StateChild, PreschoolCross-Sectional StudiesHumansInfantMass ScreeningMicrobial Sensitivity TestsNasopharynxPneumonia, PneumococcalPrevalenceRisk AssessmentStreptococcus pneumoniaeUgandaAnti-Bacterial AgentsAntibiotic resistancechildrencommunity case managementpneumoniaStreptococcus pneumoniae

Identifiers

PMID26305429
PMCPMC4816885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.